|
2025-01-27 |
2025-01-24 |
V
Vente
|
Wall Brett A.
EVP & Pres Neuroscience
Dirigeant
|
12 437
-23.3%
90,00
1 119 330 USD
|
12 437
-23.3%
|
90,00
|
1 119 330 USD
|
|
|
2025-01-10 |
2025-01-08 |
V
Vente
|
Wall Brett A.
EVP & Pres Neuroscience
Dirigeant
|
3 000
-6.9%
80,41
241 230 USD
|
3 000
-6.9%
|
80,41
|
241 230 USD
|
|
|
2025-01-10 |
2025-01-08 |
V
Vente
|
Wall Brett A.
EVP & Pres Neuroscience
Dirigeant
|
6 850
-13.5%
80,41
550 809 USD
|
6 850
-13.5%
|
80,41
|
550 809 USD
|
|
|
2024-06-11 |
2024-06-07 |
V
Vente
|
Martha Geoffrey
Chairman and CEO
Administrateur exécutif
|
1 594
-1.1%
83,82
133 609 USD
|
1 594
-1.1%
|
83,82
|
133 609 USD
|
|
|
2024-06-11 |
2024-06-07 |
V
Vente
|
Martha Geoffrey
Chairman and CEO
Administrateur exécutif
|
17 519
-10.8%
83,76
1 467 391 USD
|
17 519
-10.8%
|
83,76
|
1 467 391 USD
|
|
|
2024-04-09 |
2024-04-08 |
V
Vente
|
Marinaro Michael
EVP & President, Surgical OU
Dirigeant
|
854
-3.0%
83,14
71 002 USD
|
854
-3.0%
|
83,14
|
71 002 USD
|
|
|
2024-02-23 |
2024-02-21 |
V
Vente
|
Salmon Sean
EVP & President Cardiovascular
Dirigeant
|
16 035
-24.9%
85,12
1 364 899 USD
|
16 035
-24.9%
|
85,12
|
1 364 899 USD
|
|
|
2024-02-23 |
2024-02-21 |
V
Vente
|
Salmon Sean
EVP & President Cardiovascular
Dirigeant
|
13 066
-16.9%
85,15
1 112 570 USD
|
13 066
-16.9%
|
85,15
|
1 112 570 USD
|
|
|
2024-02-23 |
2024-02-21 |
V
Vente
|
Salmon Sean
EVP & President Cardiovascular
Dirigeant
|
1 594
-2.0%
85,06
135 586 USD
|
1 594
-2.0%
|
85,06
|
135 586 USD
|
|
|
2023-12-20 |
2023-12-19 |
VP
Vente planifiée
|
Wall Brett A.
EVP & Pres Neuroscience
Dirigeant
|
4 997
-14.7%
82,17
410 603 USD
|
4 997
-14.7%
|
82,17
|
410 603 USD
|
|
|
2023-08-25 |
2023-08-23 |
V
Vente
|
Smith Gregory L
EVP Global Ops & Supply Chain
Dirigeant
|
10 000
-17.6%
83,84
838 400 USD
|
10 000
-17.6%
|
83,84
|
838 400 USD
|
|
|
2023-08-16 |
2023-08-14 |
VP
Vente planifiée
|
Wall Brett A.
EVP & Pres Neuroscience
Dirigeant
|
1 000
-2.9%
83,38
83 380 USD
|
1 000
-2.9%
|
83,38
|
83 380 USD
|
|
|
2023-08-07 |
2023-08-04 |
VP
Vente planifiée
|
Marinaro Michael
EVP & President, Surgical OU
Dirigeant
|
1 352
-4.5%
84,11
113 717 USD
|
1 352
-4.5%
|
84,11
|
113 717 USD
|
|
|
2023-07-18 |
2023-07-14 |
VP
Vente planifiée
|
Wall Brett A.
EVP & Pres Neuroscience
Dirigeant
|
2 000
-7.7%
87,97
175 940 USD
|
2 000
-7.7%
|
87,97
|
175 940 USD
|
|
|
2023-07-12 |
2023-07-10 |
V
Vente
|
TEN HOEDT ROB
EVP and Pres. Global Regions
Dirigeant
|
3 706
-7.8%
86,58
320 865 USD
|
3 706
-7.8%
|
86,58
|
320 865 USD
|
|
|
2023-07-12 |
2023-07-10 |
V
Vente
|
TEN HOEDT ROB
EVP and Pres. Global Regions
Dirigeant
|
1 808
-4.0%
86,59
156 555 USD
|
1 808
-4.0%
|
86,59
|
156 555 USD
|
|
|
2022-12-16 |
2022-12-13 |
V
Vente
|
Salmon Sean
EVP & President Cardiovascular
Dirigeant
|
16 631
-31.5%
80,50
1 338 736 USD
|
16 631
-31.5%
|
80,50
|
1 338 736 USD
|
|
|
2022-10-17 |
2022-10-14 |
V
Vente
|
TEN HOEDT ROB
EVP and Pres. Global Regions
Dirigeant
|
2 404
-5.2%
81,54
196 015 USD
|
2 404
-5.2%
|
81,54
|
196 015 USD
|
|
|
2022-03-21 |
2022-03-18 |
VP
Vente planifiée
|
PARKHILL KAREN L
EVP & Chief Financial Officer
Dirigeant
|
682
-1.9%
110,00
75 020 USD
|
682
-1.9%
|
110,00
|
75 020 USD
|
|
|
2022-03-14 |
2022-03-11 |
V
Vente
|
Surface Carol A
SVP, Chief HR Officer
Dirigeant
|
6 000
-17.4%
105,30
631 800 USD
|
6 000
-17.4%
|
105,30
|
631 800 USD
|
|
